Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for tyrosine in Standardized Name (approximate match)

Showing 301 - 310 of 581 results

First page
Previous page
Next page
Next page

Maplirpacept

44D51T6SZH

Subunit 1 (347) Similarity Search Subunit 2 (347) Similarity Search

Sequence Search

Subunit 1 (347) Similarity Search Subunit 2 (347) Similarity Search

Status:

Investigational

Source:

NCT03530683: Phase 1 Interventional Terminated Lymphoma

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03530683

Class:

PROTEIN

Petosemtamab

Z6Z6IVE7W4

Subunit 1 (449) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (456) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03526835: Phase 1/Phase 2 Interventional Recruiting Advanced/Metastatic Solid Tumors

(2018)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03526835

Class:

PROTEIN

OZURIFTAMAB VEDOTIN

BPM6YN0KLI

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Sequence Search

Subunit 1 (451) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Status:

Investigational

Source:

INN:ozuriftamab vedotin [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/BPM6YN0KLI

Class:

PROTEIN

Azerutamig

7DGR11S93X

Subunit 1 (475) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search

Sequence Search

Subunit 1 (475) Similarity Search Subunit 2 (451) Similarity Search Subunit 3 (214) Similarity Search

Status:

Investigational

Source:

INN:azerutamig [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/7DGR11S93X

Class:

PROTEIN

ZANIDATAMAB ZOVODOTIN

HKH2GV9PVO

Subunit 1 (481) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (215) Similarity Search

Sequence Search

Subunit 1 (481) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (215) Similarity Search

Status:

Investigational

Source:

NCT03821233: Phase 1 Interventional Completed HER2-expressing Cancers

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03821233

Class:

PROTEIN

REOZALIMAB

1LO2LQW7QG

Subunit 1 (450) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (216) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (453) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (216) Similarity Search

Status:

Investigational

Source:

INN:reozalimab [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/1LO2LQW7QG

Class:

PROTEIN

ACAZICOLCEPT

W507556HV0

Subunit 1 (363) Similarity Search Subunit 2 (363) Similarity Search

Sequence Search

Subunit 1 (363) Similarity Search Subunit 2 (363) Similarity Search

Status:

Investigational

Source:

INN:acazicolcept [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/W507556HV0

Class:

PROTEIN

Ziltivekimab

AN3Y2B4SX4

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Status:

Investigational

Source:

NCT04626505: Phase 2 Interventional Completed Chronic Kidney Disease

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04626505

Class:

PROTEIN

VIBOSTOLIMAB

5XO3JF0FEK

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT04305041: Phase 1/Phase 2 Interventional Active, not recruiting Melanoma

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04305041

Class:

PROTEIN

Patritumab Deruxtecan

3XPI7EG4W8

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search Subunit 2 (447) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

Investigational

Source:

NCT04699630: Phase 2 Interventional Active, not recruiting Metastatic Breast Cancer

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04699630

Class:

PROTEIN

Protein

Protein

Protein

OZURIFTAMAB VEDOTIN

Protein

Protein

ZANIDATAMAB ZOVODOTIN

Protein

Protein

Protein

Protein

Protein

Patritumab Deruxtecan

Showing 301 - 310 of 581 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1